InsidersTradesSigma
Track the 아스테라시스 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 아스테라시스 has recorded 34 reports. Market capitalisation: €215.2bn. The latest transaction was filed on 16 July 2026 (Sale). Among the most active insiders: 서은택. All data is accessible without an account.
32
Insider Decl.
n/a
Thresholds
n/a
17 ops.
Buy Volume
n/a
2 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 5,068 of 29,063 companies
68.4
score / 100
Value48
Quality88
FCF yld1.7%
Earn yld4.6%
EV/EBITDA15.9x
ROE19%
Gross mgn79%
Net mgn24%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 July 2026
Declarations34 total
Other
Other
25 of 34 declarations
Acerca de 아스테라시스
Asterasis es una empresa que opera en el sector sanitario y farmacéutico, cotizada en el XKRX. Se enfoca en el desarrollo de soluciones innovadoras para mejorar la atención sanitaria.